NEOGEN CORP (NEOG)
$11.66-$0.08 (-0.68%) Today
Neogen Corp is develop, manufacture and market a diverse line of products and services dedicated to food and animal safety. Its Food Safety segment consists mainly of diagnostic test kits and complementary products (e.g., culture media) sold to food and animal feed producers and processors to preserve the safety and quality of food to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. These products also ensure the general hygiene of the food manufacturing environment. It also have products to determine food quality and nutritional components. Its segments are Food, Animal safety. Majority of revenue comes from Food Safety. It has presence in United states, and International market.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 1 | 370 | $4K |
| Grant or award | 10 | 1,593,296 | |
| Tax withholding / forfeiture | 3 | 25,315 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
106 Form 4 filings on record, the earliest from Oct 9, 2024, newest first. Filing history page 2 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| James C. Borel - Director | Option exercise | Common Stock | 2,025 | $6.19 | $13K | |
| James C. Borel - Director | Option exercise | Restricted Stock Units | 2,025 | $6.19 | $13K | |
| Avi Pelossof - Director | Grant or award | Common Stock | 19,386 | $6.19 | $120K | |
| Avi Pelossof - Director | Grant or award | Common Stock (Right to Buy) | 49,929 | $0.00 | - | |
 Rafael A. Rodriguez - Director | Option exercise | Common Stock | 1,777 | $6.19 | $11K | |
| Rafael A. Rodriguez - Director | Option exercise | Restricted Stock Units | 1,777 | $6.19 | $11K | |
 James P. Tobin - Director | Option exercise | Common Stock | 1,777 | $6.19 | $11K | |
| James P. Tobin - Director | Option exercise | Restricted Stock Units | 1,777 | $6.19 | $11K | |
 Amy M. Rocklin - Officer | Option exercise | Common Stock | 9,474 | $6.19 | $59K | |
| Amy M. Rocklin - Officer | Tax withholding / forfeiture | Common Stock | 2,085 | $6.19 | $13K | |
| Amy M. Rocklin - Officer | Option exercise | Restricted Stock Units | 9,474 | $6.19 | $59K | |
 Jeffrey D. Capello - Director | Grant or award | Common Stock | 19,769 | $6.07 | $120K | |
| Jeffrey D. Capello - Director | Grant or award | Common Stock (Right to Buy) | 50,814 | $0.00 | - | |
| Andrea F. Wainer - Director | Grant or award | Common Stock | 19,769 | $6.07 | $120K | |
| Andrea F. Wainer - Director | Grant or award | Common Stock (Right to Buy) | 50,814 | $0.00 | - | |
 Catherine E. Woteki - Director | Grant or award | Common Stock (Right to Buy) | 50,814 | $0.00 | - | |
| Catherine E. Woteki - Director | Grant or award | Common Stock | 19,769 | $6.07 | $120K | |
| Rafael A. Rodriguez - Director | Grant or award | Common Stock | 19,769 | $6.07 | $120K | |
| Rafael A. Rodriguez - Director | Grant or award | Common Stock (Right to Buy) | 50,814 | $0.00 | - | |
 Aashima Gupta - Director | Grant or award | Common Stock | 19,769 | $6.07 | $120K | |
| Aashima Gupta - Director | Grant or award | Common Stock (Right to Buy) | 50,814 | $0.00 | - | |
 Ronald D. Green - Director | Grant or award | Common Stock (Right to Buy) | 50,814 | $0.00 | - | |
| Ronald D. Green - Director | Grant or award | Common Stock | 19,769 | $6.07 | $120K | |
| Thierry Bernard - Director | Grant or award | Common Stock | 19,769 | $6.07 | $120K | |
| Thierry Bernard - Director | Grant or award | Common Stock (Right to Buy) | 50,814 | $0.00 | - | |
| James C. Borel - Director | Grant or award | Common Stock (Right to Buy) | 50,814 | $0.00 | - | |
| James C. Borel - Director | Grant or award | Common Stock | 19,769 | $6.07 | $120K | |
 Douglas Edward Jones - Officer | Option exercise | Common Stock | 783 | $6.04 | $5K | |
| Douglas Edward Jones - Officer | Tax withholding / forfeiture | Common Stock | 383 | $6.04 | $2K | |
| Douglas Edward Jones - Officer | Option exercise | Restricted Stock Units | 783 | $6.04 | $5K | |
| Amy M. Rocklin - Officer | Option exercise | Common Stock | 294 | $6.04 | $2K | |
| Amy M. Rocklin - Officer | Tax withholding / forfeiture | Common Stock | 115 | $6.04 | $695 | |
| Amy M. Rocklin - Officer | Option exercise | Restricted Stock Units | 294 | $6.04 | $2K | |
| John Edward Adent - Officer | Option exercise | Common Stock | 3,063 | $6.04 | $19K | |
| John Edward Adent - Officer | Tax withholding / forfeiture | Common Stock | 865 | $6.04 | $5K | |
| John Edward Adent - Officer | Option exercise | Restricted Stock Units | 3,063 | $6.04 | $19K | |
| Jeffrey D. Capello - Director | Option exercise | Common Stock | 2,071 | $5.63 | $12K | |
| Jeffrey D. Capello - Director | Option exercise | Restricted Stock Units | 2,071 | $5.63 | $12K | |
 William T. Boehm - Director | Option exercise | Common Stock | 2,071 | $5.63 | $12K | |
| William T. Boehm - Director | Option exercise | Restricted Stock Units | 2,071 | $5.63 | $12K | |
| Rafael A. Rodriguez - Director | Option exercise | Common Stock | 2,071 | $5.63 | $12K | |
| Rafael A. Rodriguez - Director | Option exercise | Restricted Stock Units | 2,071 | $5.63 | $12K | |
| James C. Borel - Director | Option exercise | Common Stock | 2,071 | $5.63 | $12K | |
| James C. Borel - Director | Option exercise | Restricted Stock Units | 2,071 | $5.63 | $12K | |
| Ronald D. Green - Director | Option exercise | Common Stock | 2,071 | $5.63 | $12K | |
| Ronald D. Green - Director | Option exercise | Restricted Stock Units | 2,071 | $5.63 | $12K | |
| John Edward Adent - Officer | Option exercise | Common Stock | 32,936 | $5.63 | $185K | |
| John Edward Adent - Officer | Tax withholding / forfeiture | Common Stock | 9,297 | $5.63 | $52K | |
| John Edward Adent - Officer | Option exercise | Restricted Stock Units | 32,936 | $5.63 | $185K | |
| James P. Tobin - Director | Option exercise | Common Stock | 2,071 | $5.63 | $12K | |
| James P. Tobin - Director | Option exercise | Restricted Stock Units | 2,071 | $5.63 | $12K | |
| Catherine E. Woteki - Director | Option exercise | Common Stock | 2,071 | $5.63 | $12K | |
| Catherine E. Woteki - Director | Option exercise | Restricted Stock Units | 2,071 | $5.63 | $12K | |
| Douglas Edward Jones - Officer | Option exercise | Common Stock | 12,940 | $5.63 | $73K | |
| Douglas Edward Jones - Officer | Tax withholding / forfeiture | Common Stock | 6,329 | $5.63 | $36K | |
| Douglas Edward Jones - Officer | Option exercise | Restricted Stock Units | 12,940 | $5.63 | $73K | |
| Aashima Gupta - Director | Option exercise | Common Stock | 2,071 | $5.63 | $12K | |
| Aashima Gupta - Director | Option exercise | Restricted Stock Units | 2,071 | $5.63 | $12K | |
| Amy M. Rocklin - Officer | Option exercise | Common Stock | 9,036 | $5.36 | $48K | |
| Amy M. Rocklin - Officer | Tax withholding / forfeiture | Common Stock | 3,534 | $5.63 | $20K | |
| Amy M. Rocklin - Officer | Option exercise | Restricted Stock Units | 9,036 | $5.63 | $51K | |
| Douglas Edward Jones - Officer | Option exercise | Common Stock | 14,294 | $5.43 | $78K | |
| Douglas Edward Jones - Officer | Tax withholding / forfeiture | Common Stock | 4,160 | $5.43 | $23K | |
| Douglas Edward Jones - Officer | Option exercise | Restricted Stock Units | 14,294 | $5.43 | $78K | |
| John Patrick Moylan - Officer | Option exercise | Common Stock | 1,985 | $5.43 | $11K | |
| John Patrick Moylan - Officer | Tax withholding / forfeiture | Common Stock | 593 | $5.43 | $3K | |
| John Patrick Moylan - Officer | Option exercise | Restricted Stock Units | 1,985 | $5.43 | $11K | |
| David H. Naemura - Officer | Option exercise | Common Stock | 14,294 | $5.43 | $78K | |
| David H. Naemura - Officer | Tax withholding / forfeiture | Common Stock | 5,947 | $5.43 | $32K | |
| David H. Naemura - Officer | Option exercise | Restricted Stock Units | 14,294 | $5.43 | $78K |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - | View on EDGAR |
NEOGEN CORP (NEOG) had 9 insider filings in the last 90 days, with the most recent on 2026-08-20. The full record for NEOG runs to 106 Form 4 filings, the earliest from 2024-10-09. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
1 insider purchase of NEOG was filed in the last 90 days, totaling $4K.
No insider sales of NEOG were filed in the last 90 days.
This page tracks NEOG Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add NEOG to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
$QDELQuidelOrtho Corp
$CLDXCelldex Therapeutics, Inc.
$MYGNMYRIAD GENETICS INC
$NTLAIntellia Therapeutics, Inc.
$ACHVACHIEVE LIFE SCIENCES, INC.
$IMDXInsight Molecular Diagnostics Inc.
$LNTHLantheus Holdings, Inc.
$CDIOCardio Diagnostics Holdings, Inc.
$TKNOAlpha Teknova, Inc.
$IDXXIDEXX LABORATORIES INC /DEReal-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
